DOI: 10.1001/jamaoncol.2017.3462

,  

,  

PMID: 29145547

Issn Print: 2374-2437

Publication Date: 2018/01/01


Print

Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

Andrew J. Sinnamon; Madalyn G. Neuwirth; Phyllis A. Gimotty; Tara C. Gangadhar; Ravi K. Amaravadi; Lynn M. Schuchter; Giorgos C. Karakousis

+ Author Information

Author Information: Department of Surgery, Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, Philadelphia

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles